GB2415137B - Lipoic acid derivatives for the treatment of atherosclerosis and arthritis - Google Patents

Lipoic acid derivatives for the treatment of atherosclerosis and arthritis

Info

Publication number
GB2415137B
GB2415137B GB0413634A GB0413634A GB2415137B GB 2415137 B GB2415137 B GB 2415137B GB 0413634 A GB0413634 A GB 0413634A GB 0413634 A GB0413634 A GB 0413634A GB 2415137 B GB2415137 B GB 2415137B
Authority
GB
United Kingdom
Prior art keywords
atherosclerosis
arthritis
treatment
acid derivatives
lipoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0413634A
Other versions
GB0413634D0 (en
GB2415137A (en
Inventor
David Sidney Leake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Reading
Cambridge Theranostics Ltd
Original Assignee
University of Reading
Cambridge Theranostics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Reading, Cambridge Theranostics Ltd filed Critical University of Reading
Priority to GB0413634A priority Critical patent/GB2415137B/en
Publication of GB0413634D0 publication Critical patent/GB0413634D0/en
Publication of GB2415137A publication Critical patent/GB2415137A/en
Application granted granted Critical
Publication of GB2415137B publication Critical patent/GB2415137B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0413634A 2004-06-18 2004-06-18 Lipoic acid derivatives for the treatment of atherosclerosis and arthritis Expired - Fee Related GB2415137B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0413634A GB2415137B (en) 2004-06-18 2004-06-18 Lipoic acid derivatives for the treatment of atherosclerosis and arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0413634A GB2415137B (en) 2004-06-18 2004-06-18 Lipoic acid derivatives for the treatment of atherosclerosis and arthritis

Publications (3)

Publication Number Publication Date
GB0413634D0 GB0413634D0 (en) 2004-07-21
GB2415137A GB2415137A (en) 2005-12-21
GB2415137B true GB2415137B (en) 2009-04-29

Family

ID=32750136

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0413634A Expired - Fee Related GB2415137B (en) 2004-06-18 2004-06-18 Lipoic acid derivatives for the treatment of atherosclerosis and arthritis

Country Status (1)

Country Link
GB (1) GB2415137B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210015788A1 (en) * 2018-03-13 2021-01-21 Nuchido Limited Compositions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090842A (en) * 1998-03-10 2000-07-18 The Regents Of The University Of California Lipoic acid analogs
US20020193323A1 (en) * 2000-11-22 2002-12-19 Inna Yegorova Compositions and methods for promoting a healthy cardiovascular system and enhancing blood flow
WO2003084532A1 (en) * 2002-04-03 2003-10-16 Avery Mitchell A Lipoic acid analogs useful as provitamins and antioxidants

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090842A (en) * 1998-03-10 2000-07-18 The Regents Of The University Of California Lipoic acid analogs
US20020193323A1 (en) * 2000-11-22 2002-12-19 Inna Yegorova Compositions and methods for promoting a healthy cardiovascular system and enhancing blood flow
WO2003084532A1 (en) * 2002-04-03 2003-10-16 Avery Mitchell A Lipoic acid analogs useful as provitamins and antioxidants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Federation proceedings, 1983, Vol.42(8), Shih, pp.2494-2497. *

Also Published As

Publication number Publication date
GB0413634D0 (en) 2004-07-21
GB2415137A (en) 2005-12-21

Similar Documents

Publication Publication Date Title
IL181303A (en) Method for the production of dihydropteridinones and some such compounds
ZA200709846B (en) Aryl alkyl acid derivatives for and use thereof
SI1802579T1 (en) Derivatives of 3-arylaminopyridine
AP2007003980A0 (en) Dibenzylamine compounds and derivatives
IL198847A (en) Process for the preparation of 2-imino-thiazolidin-4-one derivatives and some such derivatives
IL177232A0 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
GB0504365D0 (en) Superstructures for elongate members and methods of forming such superstructures
EP1858325A4 (en) Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
EP1736148A4 (en) Medical emulsion of perfluororganic compounds and method for the production thereof
PT2054045E (en) Use of 2,5-dihydroxybenzene derivatives for the treatment of arthritis and pain
EP1720893A4 (en) Compositions and methods for the systemic treatment of arthritis
PT1781145T (en) Tool to facilitate the consumption of ingestible substances
EP1874722A4 (en) Hydroxamic acid derivatives and the preparation method thereof
ZA200708033B (en) Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
EP1946007A4 (en) Anbrosteeone derivatives and method of use thereof
PL1959957T3 (en) Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosis
EP1912630A4 (en) Compositions and methods for the reduction of post-operative pain
EP1750698A4 (en) 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
EP1898940A4 (en) Inhibitors of the alpha2beta 1/gpia-iia integrin
PT1753720E (en) Process for the preparation of perindopril and salts thereof
EP1852432A4 (en) Nitrogenous heterocyclic compound and medicinal use thereof
PL1791423T3 (en) Compositions and methods for the management of hyperproliferative dermatological conditions
GB0402578D0 (en) Methods of treatment of atherosclerosis
GB2415137B (en) Lipoic acid derivatives for the treatment of atherosclerosis and arthritis
IL188010A0 (en) Procedure for the treatment of purines and products thereof

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20110618